The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Angiogenesis in cancer
Open accessAbstract
New growth in the vascular network is important since the proliferation, as well as metastatic spread, of cancer cells depends on an adequate supply of oxygen and nutrients and the removal of waste products. New blood and lymphatic vessels form through processes called angiogenesis and lymphangiogenesis, respectively. Angiogenesis is regulated by both activator and inhibitor molecules. More than a dozen different proteins have been identified as angiogenic activators and inhibitors. Levels of expression of angiogenic factors reflect the aggressiveness of tumor cells. The discovery of angiogenic inhibitors should help to reduce both morbidity and mortality from carcinomas. Thousands of patients have received antiangiogenic therapy to date. Despite their theoretical efficacy, antiangiogeic treatments have not proved beneficial in terms of long-term survival. There is an urgent need for a new comprehensive treatment strategy combining antiangiogenic agents with conventional cytoreductive treatments in the control of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Dvorak, H. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.088 · Cited by 1,573
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Pfister, D. G., Johnson, D. H., Azzoli, C. G., Sause, W., Smith, T. J., Baker Jr, S., Olak, J., Stover, D., Strawn, J. R., Turrisi, A. T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.053 · Cited by 1,413
Vascular Endothelial Growth Factor
Ferrara, N. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179663 · Cited by 1,283
Achen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A. F., Alitalo, K., & Stacker, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.548 · Cited by 1,205
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
Mandriota, S. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.672 · Cited by 978
Signal transduction to hypoxia-inducible factor 1
Semenza, G. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01168-1 · Cited by 860
Cancer cells compress intratumour vessels
Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K. (2004) · Nature · doi:10.1038/427695a · Cited by 857
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V, Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K., & Eriksson, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2576 · Cited by 803
Inai, T., Mancuso, M., Hashizume, H., Baffert, F., Haskell, A., Baluk, P., Hu-Lowe, D. D., Shalinsky, D. R., Thurston, G., Yancopoulos, G. D., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63273-7 · Cited by 757
Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., & Jain, R. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14765 · Cited by 719
Lee, C. G., Heijn, M., di Tomaso, E., Griffon, G., Ancukiewicz, M., Koike, C., Park, K. R., Ferrara, N., Jain, R. K., Suit, H. D., et al. (2000) · PubMed · Cited by 677
Herceptin acts as an anti-angiogenic cocktail
Izumi, Y., Xu, L., di Tomaso, E., Fukumura, D., & Jain, R. K. (2002) · Nature · doi:10.1038/416279b · Cited by 623
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer
COBLEIGH, M. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.013 · Cited by 488
Assignment of the Vascular Endothelial Growth Factor Gene to Human Chromosome 6p21.3
Vincenti, V., Cassano, C., Rocchi, M., & Persico, M. G. (1996) · Circulation · doi:10.1161/01.cir.93.8.1493 · Cited by 471
Interaction of endostatin with integrins implicated in angiogenesis
Rehn, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031564998 · Cited by 460
Enholm, B., Paavonen, K., Ristimäki, A., Kumar, V., Gunji, Y., Klefstrom, J., Kivinen, L., Laiho, M., Olofsson, B., Joukov, V., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201090 · Cited by 457
Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
Boocock, C. A., Charnock-Jones, D. S., Sharkey, A. M., McLaren, J., Barker, P. J., Wright, K. A., Twentyman, P. R., & Smith, S. K. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.7.506 · Cited by 456
Role of Integrins in Cancer: Survey of Expression Patterns
Mizejewski, G. J. (1999) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-122.x · Cited by 451
Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y., & Shibuya, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31273 · Cited by 406
Lymphangiogenesis and tumor metastasis: myth or reality?
Pepper, M. S. (2001) · PubMed · Cited by 366
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms
Stalmans, I., Ng, Y.-S., Rohan, R., Fruttiger, M., Bouché, A., Ÿuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214362 · Cited by 358
Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
Denekamp, J. (1993) · The British Journal of Radiology · doi:10.1259/0007-1285-66-783-181 · Cited by 358
Conn, G., Bayne, M. L., Soderman, D. D., Kwok, P. W., Sullivan, K. A., Palisi, T. M., Hope, D. A., & Thomas, K. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2628 · Cited by 355
Vascular endothelial growth factor
Ferrara, N. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00387-5 · Cited by 355
Claesson-Welsh, L., Welsh, M., Ito, N., Anand-Apte, B., Soker, S., Zetter, B., O’Reilly, M., & Folkman, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5579 · Cited by 349
Neuropilin-1 Is a Placenta Growth Factor-2 Receptor
Migdal, M., Huppertz, B., Tessler, S., Comforti, A., Shibuya, M., Reich, R., Baumann, H., & Neufeld, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22272 · Cited by 348
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., & Hanahan, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2002 · Cited by 344
Ohta, Y., Shridhar, V, Bright, R. K., Kalemkerian, G. P., Du, W., Carbone, M., Watanabe, Y., & Pass, H. I. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690650 · Cited by 335
Bellomo, D., Headrick, J. P., Silins, G. U., Paterson, C. A., Thomas, P. S., Gartside, M., Mould, A., Cahill, M. M., Tonks, I. D., Grimmond, S. M., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.2.e29 · Cited by 333
Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human Tumors
Salven, P., Lymboussaki, A., Heikkilä, P., Jääskela-Saari, H., Enholm, B., Aase, K., von Euler, G., Eriksson, U., Alitalo, K., & Joensuu, H. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65550-2 · Cited by 328
Orlandini, M., Marconcini, L., Ferruzzi, R., & Oliviero, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11675 · Cited by 315
Jussila, L., Valtola, R., Partanen, T. A., Salvén, P., Heikkilä, P., Matikainen, M., Renkonen, R., Kaipainen, A., Detmar, M. J., Tschachler, E., et al. (1998) · PubMed · Cited by 312
Yonemura, Y., Endo, Y., Fujita, H., Fushida, S., Ninomiya, I., Bandou, E., Taniguchi, K., Miwa, K., Ohoyama, S., Sugiyama, K., et al. (1999) · PubMed · Cited by 311
Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus
Lyttle, D. J., Fraser, K. M., Fleming, S. B., Mercer, A. A., & Robinson, A. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.84-92.1994 · Cited by 303
Niki, T., Iba, S., Tokunou, M., Yamada, T., Matsuno, Y., & Hirohashi, S. (2000) · PubMed · Cited by 288
Splitting vessels: Keeping lymph apart from blood
Rafii, S., & Skobe, M. (2003) · Nature Medicine · doi:10.1038/nm0203-166 · Cited by 264
Joukov, V., Kumar, V., Sorsa, T., Arighi, E., Weich, H., Saksela, O., & Alitalo, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6599 · Cited by 255
Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.
Dhanabal, M., Ramchandran, R., Volk, R., Stillman, I. E., Lombardo, M., Iruela‐Arispe, M. L., Simons, M., & Sukhatme, V. P. (1999) · PubMed · Cited by 240
O-charoenrat, P., Rhys-Evans, P., & Eccles, S. A. (2001) · Cancer · doi:10.1002/1097-0142(20010801)92:3<556::aid-cncr1355>3.0.co;2-q · Cited by 232
Multiple forms of angiostatin induce apoptosis in endothelial cells.
Lucas, R., Holmgren, L., Garcia, I., Jiménez, B., Mandriota, S. J., Borlat, F., Sim, B. K. L., Wu, Z., Grau, G. E., Shing, Y., et al. (1998) · PubMed · doi:10.1182/blood.v92.12.4730 · Cited by 227
VEGF-A, VEGF-C, and VEGF-D in Colorectal Cancer Progression
George, M. L., Tutton, M. G., Janssen, F., Arnaout, A., Abulafi, A. M., Eccles, S. A., & Swift, R. I. (2001) · Neoplasia · doi:10.1038/sj.neo.7900186 · Cited by 223
Decaussin, M., Sartelet, H., Robert, C., Moro, D., Claraz, C., Brambilla, C., & Brambilla, E. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199908)188:4<369::aid-path381>3.0.co;2-x · Cited by 212
Wickström, S. A., Alitalo, K. K., & Keski‐Oja, J. (2002) · PubMed · Cited by 207
Majima, M., Hayashi, I., Muramatsu, M., Katada, J., Yamashina, S., & Katori, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703327 · Cited by 203
Yonekura, H., Sakurai, S., Liu, X., Migita, H., Wang, H., Yamagishi, S.-I., Nomura, M., Abedin, M. J., Unoki, H., Yamamoto, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35172 · Cited by 194
Baldwin, M. E., Catimel, B., Nice, E. C., Roufail, S., Hall, N. E., Stenvers, K. L., Karkkainen, M. J., Alitalo, K., Stacker, S. A., & Achen, M. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100097200 · Cited by 191
Angiostatin suppresses malignant glioma growth in vivo.
Kirsch, M., Strasser, J., Allende, R., Bello, L., Zhang, J., & Black, P. M. (1998) · PubMed · Cited by 185
Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer
Kurebayashi, J., Otsuki, T., Kunisue, H., Mikami, Y., Tanaka, K., Yamamoto, S., & Sonoo, H. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00844.x · Cited by 174
Out of air is not out of action
Bottaro, D. P., & Liotta, L. A. (2003) · Nature · doi:10.1038/423593a · Cited by 168
Kajita, T., Ohta, Y., Kimura, K., Tamura, M., Tanaka, Y., Tsunezuka, Y., Oda, M., Sasaki, T., & Watanabe, G. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1882 · Cited by 164
Tumor-induced neovascularization in the mouse eye.
Muthukkaruppan, V., Kubai, L., & Auerbach, R. (1982) · PubMed · Cited by 158
Yokoyama, Y., Jones, D. S., Licence, D., Yanaihara, A., Hastings, J. M., Holland, C. M., Emoto, M., UMEMOTO, M., Sakamoto, T., Sato, S., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600701 · Cited by 152
André, T., Kotelevets, L., Vaillant, J., Coudray, A. M., Weber, L., Pr�vot, S., Parc, R., Gespach, C. P., & Chastre, E. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000415)86:2<174::aid-ijc5>3.0.co;2-e · Cited by 149
Clinical significance of vascular endothelial growth factor‐C (VEGF‐C) in breast cancer
Kinoshita, J., Kitamura, K., Kabashima, A., Saeki, H., Tanaka, S., & Sugimachi, K. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010692132669 · Cited by 140
Teicher, B. A. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437479 · Cited by 125
Amioka, T., Kitadai, Y., Tanaka, S., Haruma, K., Yoshihara, M., Yasui, W., & Chayama, K. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00106-5 · Cited by 123
Stack, M. S., Gately, S. T., Bafetti, L. M., Enghild, J. J., & Soff, G. A. (1999) · Biochemical Journal · doi:10.1042/bj3400077 · Cited by 116
Ma, J., Pulfer, S. K., Li, S., Chu, J., Reed, K. L., & Gallo, J. M. (2001) · PubMed · Cited by 115
Advances in the Treatment of Metastatic Colorectal Cancer
Goldberg, R. M. (2005) · The Oncologist · doi:10.1634/theoncologist.10-90003-40 · Cited by 110
Hirai, M., Nakagawara, A., 大崎, 達., Hayashi, Y., Hirono, M., & Yoshihara, T. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6056 · Cited by 109
Two Steps Forward in the Treatment of Colorectal Cancer
Mayer, R. J. (2004) · New England Journal of Medicine · doi:10.1056/nejme048098 · Cited by 105
VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice
Kiba, A., Sagara, H., Hara, T., & Shibuya, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03033-4 · Cited by 96
Tournaire, R., Simon, M., le Noble, F., et al. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400100 · Cited by 88
Treatment of localized esophageal cancer
BRENNER, B. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.04.015 · Cited by 47
Cited by
Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
Mashouri, L., Yousefi, H., Aref, A. R., Ahadi, A. M., Molaei, F., & Alahari, S. K. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0991-5 · Cited by 1,363
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
Vermot, A., Petit-Härtlein, I., Smith, S. M. E., & Fieschi, F. (2021) · Antioxidants · doi:10.3390/antiox10060890 · Cited by 766
Cancer related inflammation: the macrophage connection
Sica, A., Allavena, P., & Mantovani, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.028 · Cited by 601
Boroumand Moghaddam, A., Namvar, F., Moniri, M., Md. Tahir, P., Azizi, S., & Mohamad, R. (2015) · Molecules · doi:10.3390/molecules200916540 · Cited by 531
Metadata
- Authors
- Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M.
- Venue
- Vascular Health and Risk Management
- Publisher
- Informa UK Limited
- Published
- 2006-08
- Volume
- 2
- Issue
- 3
- Pages
- 213-219
- ISSN
- 1176-6344 (ISSN-L)
- OpenAlex
- W2032347891
- Cited by
- 1,434
- References
- 88
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.